Drug Launch Modeling & Commercial Evaluation Specialist
Job Description
IXO is seeking a U.S.-based pharmaceutical commercial or forecasting practitioner for paid remote expert evaluation. The work examines whether assessments of medicines and drug-development programs use credible commercial assumptions and well-reasoned launch expectations.
What you will contribute
Create and critique evaluation rubrics for commercial drugs and development programs. Define the considerations that distinguish a defensible forecast from one whose apparent precision exceeds the supporting evidence.
Build or review launch curves, including uptake, peak market share and the trajectory over time. Examine the choice of comparable launches, the speed of the commercial ramp, the assumed peak and the consequences of loss of exclusivity. Explain whether those assumptions hold together and where a different judgment would materially affect the forecast.
Apply the analysis across the agreed set of launches. Expected contributions include launch-model work or critiques and assessment criteria that make the commercial reasoning explicit. The objective is to evaluate the quality of the assumptions, rather than simply reproduce a forecast's headline number.
Experience required
You must be based in the United States, with at least five years in pharmaceutical commercial forecasting, analytics or strategy. Familiarity with biotechnology and pharmaceutical development programs is required, along with practical experience building or critiquing drug-launch and uptake models.
Professionals from pharmaceutical sales teams can also be considered when they bring the relevant commercial and launch-modeling experience. A sales title alone does not replace the required experience with forecasting or model critique. This listing adds no mandatory degree or professional designation.
Engagement
Compensation is $140 • $220/hr USD. An initial 10–20 hours over 1–2 weeks is an indicative planning estimate; IXO will confirm the assignment, schedule and deliverables before work begins. Future work is not guaranteed.
Use only authorized materials and general knowledge you may lawfully share. Do not provide confidential product forecasts, non-public launch plans, customer information, employer datasets or proprietary research belonging to another organization.